In the heart, in situ local myocardial blood flow (MBF) varies greater than 10-fold between individual areas and displays a spatially heterogeneous pattern. To analyze its molecular basis, we analyzed protein expression of low and high flow samples (300 mg, <50% or >150% of mean MBF, each n=30) of six beagle dogs by 2-D polyacrylamide gel electrophoresis (380±78 spots/gel). In low flow samples, dimethylarginine dimethylaminohydrolase (DDAH1) was increased greatly (+377%, compared with high flow samples). This increase resulted in a 75% reduction of asymmetric dimethylarginine (ADMA), the potent endogenous inhibitor of NO synthase, whereas eNOS showed no difference. Low flow samples exhibited enhanced expression of GAPDH (+89%) and phosphoglycerate kinase (+100%), whereas hydroxyacylCoA dehydrogenase, electron transfer flavoprotein, myoglobin, and desmin were decreased. Assessing local MBF on different days within 2 weeks revealed a high degree of MBF stability (r 2 > 0.79). Thus, stable differences in local MBF are associated with significant differences in local gene and protein expression. In low flow areas, the increased DDAH1 reduces ADMA concentration and NOS inhibition, which strongly suggests enhanced NO formation. Low flow areas are also characterized by a higher glycolytic and a lower fatty acid oxidation capacity. Both the shift in substrate utilization and the rise in NO may contribute to the known lower oxygen consumption in these areas.
D
espite an apparent morphological uniformity within the left ventricular wall; for example, in terms of capillary, myofibril, and mitochondrial density (1) , there is a substantial spatial variation of local myocardial perfusion. This spatial heterogeneity has been observed by indicator dilution techniques (2) , molecular tracers (3, 4) , microspheres (5) , and recently also by magnetic resonance imaging techniques (6) in various species (e.g., baboon, dog, sheep, rabbit, rat) (for review [7, 8] ). When studied at a spatial resolution of 200 µl (sample mass 200 mg) in the dog heart in situ, about 1/10 of the left ventricular myocardium receives <50% and another 1/10 more than 150% of the average oxygen and substrate supply (1, 9) . This greater than threefold difference in local perfusion between individual areas of low and high flow is present in all myocardial layers and exceeds the minor transmural flow gradient (1.2 to 1) by far.
The spatial heterogeneity of perfusion observed at a given point in time may be regarded as a snapshot picture of local perfusion, resembling a patchwork pattern in each myocardial tissue layer. Because both coronary flow and myocardial capillary perfusion vary with time, due to the temporal changes in aortic and intramural pressure in the course of the cardiac cycle, the temporal stability of the flow distribution was an important question. Based on the sequential application of microspheres, early studies demonstrated a temporal component to the local heterogeneity of perfusion already on a time scale of less than 4 min (3, 10) . These data seemed to indicate that the spatial heterogeneity of perfusion represented a fluctuating or "twinkling" pattern, possibly driven primarily by microvascular components. However, later studies demonstrated that this fluctuation was relatively small compared with the absolute difference in local perfusion between low and high flow areas (e.g., refs. 8, 11) . It is worth noting that, although a transient adrenergic stimulation increased local flow both in low and high flow areas, local flow returned to its initial value within an hour (12) . Also fluorescent microspheres applied at a 2-month interval (13) appeared to demonstrate a constant deposition pattern, suggesting long-term stability of local flow. A quantitative assessment of the temporal heterogeneity of local flow, however, extending over days or weeks has not been undertaken so far.
Spatial heterogeneity cannot only be observed for myocardial perfusion, but also for cardiac metabolism and energy turnover. Compared with low flow areas, high flow regions are characterized by a higher glucose uptake and intracellular phosphorylation (1, 14) as well as a greater fatty acid permeability and uptake (15, 16) . In fact, we have demonstrated recently that the elevated perfusion in high flow regions is associated with a proportionally higher turnover of the citric acid (TCA) cycle and thus oxygen consumption (17) . The close correlation between local flow and oxygen consumption most likely explains why biochemical indices of ischemia, such as adenosine or lactate, are not increased in low flow regions under basal conditions (1, 18) . A higher energy demand in high flow regions may be the reason why high flow regions are more likely affected by infarction following ischemia (19) . However, the functional and molecular bases of this spatial heterogeneity have not been elucidated up to now.
Provided that substantial differences in substrate metabolism and energy turnover between individual left ventricular areas were present not only for hours but for days or weeks, a distinct response of myocardial gene and protein expression may be expected. In line with this hypothesis, subtle differences in enzyme activity between low and high flow regions have been reported in the past (1, 20) , whereas no morphological differences were observed (1). It was thus the goal of the present study to assess the myocardial protein expression in low and high flow areas by using a comprehensive proteomics approach. Furthermore, we analyzed whether the spatial heterogeneity of myocardial perfusion was stable for a period of up to 2 weeks.
MATERIALS AND METHODS
Studies were conducted in beagle dogs of both sexes by using procedures and protocols concordant with the Guiding Principles in the Care and Use of Animals endorsed by the American Physiological Society and were approved by the local government.
Experimental preparation
Seven dogs weighing 15-22 kg were instrumented after an overnight fast and a 10-day period of on-site conditioning. Similar to previously published procedures (21) , left atrial and aortic catheters were placed under general anesthesia for later measurements of flow by microspheres (22) . Animals were allowed to recover for at least 10 days. Subsequently, in 6 out of 7 animals differently colored fluorescent microspheres (15 µm, 5 × 10 6 ) were applied on days 1, 3, 5, 7, 9, 11, and 13 via the atrial catheter in the awake animal while simultaneously withdrawing blood from the aorta (10 ml/min) into a virtual reference organ. On the final day of the experiment, fluorescent microspheres were given simultaneously with radioactively labeled microspheres ( 46 Sc) in all dogs. Thereafter, the animals were anaesthetized as previously described (17) . Following thoracotomy and pericardiotomy, the left ventricular free wall was excised and rapidly freeze-clamped between metal blocks cooled with liquid nitrogen.
Flow measurements and sample selection
The frozen tissue was lyophilized and cut into 198 ± 23 samples (n=7 hearts) of an average dry mass of 59.4 ± 19.4 mg (n=1385 samples) according to a standardized scheme (4 transmural slices, approximately 8 rows × 8 columns). The deposition of radioactive microspheres was measured by γ-scintigraphy for calculations of local and overall average flow as described in detail before (17) . This enabled the selection of low and high flow samples for later proteome analysis, which was performed in 6 out of 7 hearts. Low flow samples were characterized by a local flow below 50% of the overall average flow, and high flow samples by a local flow above 150%. Out of every 2nd column, a total number of 5 low and 5 high flow samples were taken per heart. The fluorescent microspheres of these samples were recovered as described below. Additional low and high flow samples were used for analysis of the local concentration of asymmetric dimethylarginine (ADMA), total lipid content or mRNA expression.
To assess temporal heterogeneity of local flow, all remaining samples as well as the arterial reference samples were extracted by 4 M KOH (max. 4 h, 50°) and filtered. The fluorescent microspheres on the filter were extracted by 2 ml 2-ethoxyethylacetate (2 h), and the fluorescence was measured at the appropriate excitation and emission wavelengths (22) by using a Fluoromax-3 spectrofluorometer (Jobin-Yvon, Longjumeau, France) and 1.5-nm slits for both excitation and emission. Simultaneous injection of fluorescent (e.g., yellow-green) and radioactive microspheres ( 46 Sc, see above) resulted in identical mean flows (1.18 ± 0.33 and 1.12 ± 0.33 ml/min per g, respectively) and CV of the normalized flows (see results, Table 2 ), thereby validating the fluorescent microsphere technique.
Sample preparation for proteome analysis
All steps were carried out on ice. Lyophilized samples were chopped and subsequently rehydrated in 2 ml lysis buffer (9.5 M urea, 2% 3-[(3Cholamidopropyl)dimethyl ammonio]-1-propanesulfonate [CHAPS], 1% dithiothreitol [DTT]) for 30 min. After rehydration, 3 ml lysis puffer were added and the tissue was solubilized for 5 min by using a Potter homogenisator. A 500-µl aliquot of the sample was taken for 2-D PAGE analysis. Microspheres were recovered from the remaining 4.5 ml of the homogenate as described above. The 500 µl sample was centrifuged (14,000 UPM, 10ûC, 10 min) in order to remove insoluble connective tissue. The protein concentration was determined by a modified Bradford assay (23) . The sample was divided into 100 µl aliquots, which were stored at -80ûC.
2D-PAGE
Each sample was analyzed in duplicate by 2D-PAGE. Isoelectric focusing (IEF) was performed by using immobilized pH gradients (IPGs) and the IPGphor system (Amersham Pharmacia Biotech, Uppsala, Sweden). IPG strips (18 cm, pH 3-10 NL) were rehydrated in 350 µl sample solution (8 M urea, 1% CHAPS, 0.5% IPG buffer pH 3-10, traces of bromphenol blue) containing 120 µg protein for analytical gels and up to 1.5 mg protein for preparative gels. During rehydration (12 h), a low voltage of 30 V was applied for improved entry of high molecular weight proteins (24) . Subsequently, isoelectric focusing was performed for ~80,000 Vh (1 h 500 V, 1 h 1,000 V, 10 h 8,000 V). After IEF, the IPG strips were stored between plastic foil at -80ûC.
Second dimension (SDS-PAGE) electrophoresis was performed on a SE 660 vertical electrophoresis unit (Amersham Pharmacia Biotech). Before SDS-PAGE, each IPG strip was incubated for 15 min in 5 ml equilibration buffer (50 mM Tris/HCl, pH 8.8; 6 M urea; 30% glycero; 2% SDS; traces of bromphenol blue) containing 1% DTT and for additional 15 min in 5 ml of the same buffer containing 2.5% iodoacetamide instead of DTT. Equilibrated IPG strips were placed on top of the gel (total acrylamide concentration 13%, gel size: 1 mm × 17 cm × 24 cm) and fixed in place by agarose sealing solution (25 mM Tris, 192 mM glycine, 0.5% low gelling agarose, traces of bromphenol blue). Four gels were run simultaneously (settings: 15 min 15 mA per gel, 6 h 30 mA per gel). Analytical gels were silver-stained according to the method described by Blum (25) . Preparative gels were stained by coomassie blue R250.
Image analysis
The gels were digitized by using a UMAX (Fremont, CA) PowerLook III scanner calibrated by a photographic step tablet (Kodak, Rochester, NY). The scanning parameters of the Labscan 3.0 software (Amersham Pharmacia Biotech) were set to 300 dpi, 8-bit scale, blue channel. Gel images were evaluated by the Image Master 2D Elite 3.10 software (Amersham Pharmacia Biotech). Typical gels displayed about 900 individual protein spots. Faint spots showing a spot volume (spot area multiplied by the mean gray value) below 0.05% of the sum of all spots were excluded from the statistical analysis because they exhibited high standard deviations. A reference gel was created from gels of various high and low flow areas. This reference gel containing 770 spots served as an index to the spots on individual gels and was a matrix for data allocation. Subsequently, each gel was matched to this reference gel. Background subtraction was performed by the "mode of nonspot" option (setting: 17 pixel). To compensate for slight differences in gel staining, we divided all spot volumes (spot area multiplied by the mean gray value) within a gel by the sum of the spot volumes of 29 prominent spots. These spots were selected because they showed differences smaller than 10% between high and low flow samples in explorative experiments.
Protein identification
Coomassie blue-stained spots were excised from preparative gels. Prior to in-gel digestion, the gel sample was cut into ~1 mm 3 pieces, which were washed three times under vigorous shaking with 25 mM ammonium carbonate buffer pH 8.0 / 50% acetonitrile and freeze-dried. The pieces were taken up again in 25 mM ammonium carbonate (pH 8.0) containing 0.1 mg/ml trypsin and incubated overnight at 37°C. The peptides were extracted from the gel pieces by sonification, first in 5% formic acid / 50% acetonitrile (twice for 10 min each), and then in 100% acetonitrile (10 min). The extract was dried by vacuum centrifugation and desalted on C18 ZipTips. The peptides were analyzed by nanospray ESI-MS/MS by using a SCIEX Q-STAR system (PE Applied Biosystems, Foster City, CA). Peptide sequences were identified by mascot database search (www.matrixscience.com) or de novo sequencing followed by blast database similarity search (www.ncbi.nlm.nih.gov/BLAST/). Some prominent proteins were identified unambiguously by gel comparison with the Harefield Dog Heart (Ventricle) protein database (26) .
Amino acid analysis
The amounts of the amino acids L-arginine, asymmetrical dimethyl-L-arginine (ADMA) and symmetrical dimethyl-L-arginine (SDMA) were determined by HPLC (Waters, Nova Pak C18 column, Milford Massachusetts) using precolumn derivatization with orthophtaldialdhyde (OPA) essentially as described (27) . High and low flow samples were ground in a mortar under liquid nitrogen and subsequently extracted with 1 ml 2% 5-sulfosalicylic acid. The precipitated protein was removed by centrifugation. Basic amino acids were prepurified from the supernatant by solid-phase extraction using OASIS MCX cation exchange resin. The absorption of OPAmodified amino acids was detected at 230 nm.
Quantitative PCR
Total RNA was isolated from high flow and low flow samples. We measured actin, dimethylarginine dimethylaminohydrolase 1 (DDAH1), and eNOS mRNA by real-time quantitative PCR using the GeneAmp 5700 sequence detection system (PE Applied Biosystem, Foster City, CA). Degenerated oligonucleotide primers for canine DDAH1 were constructed according to a region of the DDAH sequence that was highly conserved between human and rat. Following primers were used: forward primer DDAH: 5′-GSAGG-AAGGAGGTTGACATGA-3′; reverse primer DDAH: 5′-RGACCCWATTGCGATCAGGTT-3', forward primer eNOS: 5′-TAC AGG ACA CAG GAT GGA CTG G-3', reverse primer eNOS: 5′-CTA AGA TGC AAG GCA GAC TGG G-3′, forward primer β-actin: 5′-AATCATGCGGTATCCACGAGA-3′; reverse primer β-actin: 5′-ATACAGGTCCTTACGGATGTCCA-3′.
The comparative C T method was used for relative quantification. Threshold cycle, C T , which correlates inversely with the target mRNA levels, was measured as the cycle number at which the SYBR green fluorescence increases above a threshold level. Relative quantification was performed relating the number of cycles of DDAH to actin at C T 0.5 and at C T 1.0. The amplification efficacy was determined for each primer pair by analysis of the slope of the linear part in the log fluorescence vs. cycle number plot. Because cycle efficiency was 100% in this range, relative amount was determined by using the formula 2 ∆C T where ∆C T describes the difference between actin and DDAH.
Determination of total lipid content
High and low flow samples were extracted with 12.5% HCl (1,000 µl per 50 mg dw) and toluene (500 µl per 50 mg dw). The two-phase mixture was incubated at 100°C for 2 h with repeated vigorous mixing. The organic phase was collected and dried with anhydrous sodium sulfate. Sodium sulfate was removed by centrifugation. The organic phase was heated to dryness at 90°C. The residue consisting of the extracted lipids was weighted.
Materials
Fluorescent microspheres (FluoSpheres were obtained from Molecular Probes, Eugene, OR) and radioactive microspheres from NEN (Boston, MA 
Statistics
Data are given as mean ± SE. Dry weight was assumed to be 20% of wet weight, and the tissue density taken to be 1 g/ml. To calculate the true spatial heterogeneity of flow, we used the following relation:
CV obs 2 = CV spat 2 + CV meth 2 + CV temp 2 (11) CV meth was assessed by the simultaneous injection of differently labeled microspheres, CV temp by the analysis of microsphere deposition density in individual samples following sequential application of differently labeled microspheres.
In order to identify proteins that displayed different expression in low and high flow samples, we established the following criteria: 1) The protein expression had to differ by more than 30% when comparing high flow with low flow samples or vice versa. Changes below 30% were considered to be of low biological relevance. 2) Statistical comparison of the spot volumes of all low and all high flow samples (each n=30 samples, nonpaired t-test) had to reveal a significant difference (P < 0.05). 3) Because low or high flow areas of one heart are not completely independent from each other, also comparison of the average spot intensity of all low and high flow areas within the individual hearts (n=6 hearts) by Student's paired t-test had to reveal a significant difference (P < 0.05). All three requirements had to be met before a significant difference in the protein expression level was considered to be relevant.
RESULTS

Spatial heterogeneity of myocardial perfusion
In the awake animal under basal conditions, average myocardial perfusion was 1.12 ± 0.33 ml/min per g wet weight as measured by radioactive microspheres ( 46 Sc). Heart rate was 130 ± 17 min -1 and end-diastolic and peak systolic arterial pressure 86 ± 10 and 140 ± 22 mmHg, respectively (n=7). Local myocardial flow was determined in a total of 1385 individual samples with an average dry mass of 59 ± 19 mg. Flow was normalized to the average flow of each heart. The coefficient of variation (CV) of the normalized flow was 0.34 at a spatial resolution of 295 µL, and 0.28 following pairing of neighboring samples (9) to obtain a spatial resolution of about 1% of the left ventricular free wall analyzed. Approximately 6% of the samples received a flow below 0.5 of the average and 11% of the samples were supplied by less than 0.6 of the average. In addition, 6% of samples received more than 1.50 of the normalized mean flow, whereas 99% of all individual samples ranged from 0.16 to 2.16 of the mean. There was up to a 14-fold difference in local flow between individual areas, demonstrating the substantial extent of spatial heterogeneity of myocardial blood flow.
Differential protein expression in low and high flow areas
The local protein expression was analyzed by 2D-PAGE in low and high flow areas (<50 % or >150% of average flow). Representative gels are shown in Figure 1 . A total number of 30 low and 30 high flow samples (n=5 each from 6 dogs) were analyzed in duplicate. Approximately 380 spots on each gel were suitable for quantitative analysis, with identical numbers of spots in low and high flow samples (389 ± 82 and 370 ± 75, respectively, n=60 gels each). The individual spot volumes were quantified and the spots of each individual gel mapped to a reference gel. This enabled the comparison of spot volumes in different gels and flow groups.
The great majority of spots showed a similar spot volume in low and high flow regions, as already apparent from the gels shown in Figure 1 . Out of the 770 spots in the reference gel, 61 spots showed differences (P<0.05) in spot volume when comparing all 30 low and 30 high flow samples. When analyzing the average difference in spot volume between low and high flow samples within each heart, 63 spots displayed a different expression. Out of these spots, about 50% (30 spots) showed differences in both the paired and the unpaired comparison. To obtain an even more conservative assessment of differences in protein expression, only those spots were followed that differed by at least 30% and which could be properly quantified in at least 100 out of 120 individual gels. On this basis, a total of 12 spots were identified that showed either an enhanced expression in high flow regions (6 spots) or an enhanced expression in low flow regions (6 spots). Figure 2 relates the relative expression levels (spot volumes) of these spots in high flow regions to that in low flow regions. Spots with an enhanced expression in high flow areas are depicted above the line of identity, and spots with an enhanced expression in low flow areas below the line of identity.
Protein identification and related metabolites
To identify those proteins displaying differential expression in low and high flow regions, preparative gels were run and individual spots analyzed by ESI-MS/MS. Out of the 12 proteins differentially expressed, 8 proteins could be identified unambiguously based on amino acid sequences of at least two internal peptide fragments ( Table 1) . Three of the unidentified proteins were present in very low amounts near the detection limit. Although MS/MS spectra were obtained, it was not possible to identify any appropriate peptide sequences by de novo sequencing. For one additional protein two short peptide sequences (ELVDALL and LDVLQL) could be deduced from MS/MS spectra, which gave no significant database hits.
The protein displaying the greatest relative change in expression levels, spot 273 (Fig. 2) , was already shown in the inset in Figure 1 . It was identified to be dimethylarginine dimethylaminohydrolase 1 (DDAH1). The expression of DDAH1 was much more pronounced in low than in high flow areas (Fig. 3) . This was not only true on the protein (+377%, P<0.001), but also on the mRNA level (+340%, P<0.01, Fig. 3 ). DDAH1 catalyses the hydrolytic cleavage of asymmetric dimethyl-L-arginine (ADMA), which is a potent inhibitor of NO synthase (28, 29) .
To verify that the enhanced expression of DDAH1 was associated with a lower concentration of its substrate, ADMA, the tissue content of this NOS inhibitor was analyzed by HPLC. This revealed that ADMA in low flow areas was reduced to 5.5 µM, only 25% of the ADMA content of high flow samples (n=10-11 samples each, P<0.01, Fig. 3) . In low flow areas, the amount of L-arginine was reduced by 45% (59 ± 17 vs. 107 ± 45 µM, P<0.05). In contrast, no differences in eNOS mRNA expression were observed between low and high flow samples, as demonstrated by quantitative PCR (Fig. 3) . SDMA, which is not a substrate of DDAH1 and does not inhibit eNOS activity, was not altered.
Moreover, proteins directly related to substrate use and energy metabolism were altered significantly in areas of low local flow compared to those of high flow. In low flow areas, glycerinaldehyde-3-phosphate dehydrogenase (GAPDH) (spot 350) and phosphoglycerate kinase 2 (PGK2) (spot 252), both part of the glycolytic pathway, were increased by 88% and 100%, respectively (P<0.01). Conversely, short chain 3-hydroxyacyl CoA dehydrogenase (HADH) (spot 302) and electron transfer flavoprotein beta subunit (ETF) (spot 371), both part of the fatty acid oxidation pathway, were significantly reduced in their expression level (-30% and -23%, respectively; P<0.01). This apparent shift towards glucose oxidation in low flow areas was associated with a significantly increased total fat content in low flow samples (56 ± 12 vs. 32 ± 5 mg/g; P<0.001, each n=7 samples derived from 2 hearts). Low flow areas were also characterized by a reduced myoglobin content (spot 489, -23%; P<0.01). The intermediate filament desmin (spot 134 and spot 135), linking the myofibrils by surrounding the Z-discs, also displayed decreased expression in low flow areas (-33% and -25%, respectively; P<0.05).
To exclude that major differences in tissue composition may account for the observed differences in protein expression several marker proteins were identified. Neither haptoglobin nor hemoglobin (plasma space and erythrocyte volume), neither mitochondrial marker proteins (isocitrate dehydrogenase subunit alpha, cytochrome c oxidase polypeptide Va, ATP synthase beta chain) nor myofibrillar marker proteins (e.g., myosin light chain 1, ventricular isoform (MLC 1) or tropomyosin alpha chain) showed any difference in their level of expression.
Temporal flow heterogeneity
Because the differences in the local proteome pattern are suggestive of long-term temporal stability of local flow, the temporal heterogeneity of local myocardial perfusion was assessed. Applying differently colored fluorescent microspheres every 2nd day for a study period of almost 2 weeks enabled the determination of local flow (e.g., on the first day (day 1) and the last day [day 13] of this period). When relating local myocardial perfusion on day 1 to that measured 13 days later a very close correlation was observed, r 2 ranging from 0.79 to 0.90 in the individual hearts. As shown in Figure 4 , areas with a low local flow on day 1 displayed a low local flow also on day 13 (e.g., heart #1), and areas characterized by a high local perfusion on day 1 were still high flow areas on day 13. This temporal stability was consistently observed in all hearts (Fig. 4) . Also when relating the local perfusion of each day of microsphere application to the flow measured on the final day, a close correlation was observed, r 2 being 0.79 ± 0.07 on average.
To describe the heterogeneity of myocardial perfusion in a more quantitative manner, the true temporal and spatial heterogeneity (CV temp and CV spatial ) were calculated. This required an assessment of the methodological error by simultaneous application of 2 fluorescent microspheres. Consistent with previous reports (11), the coefficient of variation describing the methodological error of the measurement (CV meth ) was small ( Table 2 ). On the basis of the temporal variability of microsphere deposition in each individual sample (after 6-7 microsphere injections), the true temporal heterogeneity (CV temp ) was assessed, which again was small. As a result CV spatial , an index of the true spatial heterogeneity of blood flow was close to the observed CV obs (Table 2 ). This agrees fully with the high temporal stability of local flow shown in Figure  4 .
DISCUSSION
The present study demonstrates that the spatial distribution of left ventricular perfusion is stable for weeks. Areas identified by a low local flow are characterized by a specific protein expression pattern as revealed by a high-resolution analysis of the myocardial proteome. Compared with high flow areas, low flow areas display an increased level of ADMA dimethylaminohydrolase. This translates into a 75% decrease in local ADMA and, thus, less NO synthase inhibition, strongly suggesting enhanced NO formation. Low flow areas are also characterized by an enhanced glycolytic capacity and a decreased capacity for fatty acid oxidation. The data indicate that low flow areas, characterized by a continuously reduced energy demand and turnover, show a shift from fatty acid oxidation to glycolysis. Both this shift and the enhanced level of NO will contribute to the reduced oxygen consumption of low flow areas, thereby representing a homeostatic mechanism.
Myocardial proteome of low and high flow regions
When studying the relation between local protein expression and local flow, we found that most proteins displayed a similar level of expression in low and high flow regions. Specifically, marker proteins for the intravascular and mitochondrial compartments, as well as for the myofibrillar apparatus, showed no difference (see Table 1 ). This finding is consistent with a previous report of no apparent morphological differences in the dog heart in vivo (1) . The present study underlines the assumption that the ventricular wall is a homogenous tissue, with low and high flow regions displaying a similar histological texture, but, paradoxically, major differences in flow and energy turnover.
Out of an average of 380 protein species per sample, only 12 were expressed differentially (see Table 1 ). The proteins identified delineate a close link between local flow and energy turnover on the one hand, and a) cardiac NO formation and b) energy metabolism on the other hand.
NO formation
We found that DDAH1; that is, ADMA dimethylaminohydrolase, was almost four times increased in low flow regions, both on the protein and the mRNA level. This resulted in a reduction of its substrate ADMA by 75% in low flow samples (5.5 vs. 22.4 µM). ADMA is known as a potent endogenous inhibitor of all isoforms of NO synthase (29) . The inhibitor constant (K i ) of the endothelial NO-synthase (eNOS) for ADMA is in the range of 1µM and thus lower than its Michaelis constant (K M ) for arginine (about 3µM) (30) . Because the expression of eNOS is similar in high and low flow regions, the low tissue concentrations of ADMA in low flow regions will result in less inhibition of eNOS and an increased NO formation, inducing a distinct vasodilatation in these regions. In line with this conclusion, blockade of NOS activity by L-NAME induced a greater decrease in flow in low flow regions in a previous study (31) .
In addition to the increased NO formation, a decreased NO inactivation may further enhance local NO. We demonstrated recently that myoglobin, in addition to its function as O 2 carrier, serves as an effective scavenger of NO (32) . In consequence, the reduced myoglobin content in low flow regions observed in this study may diminish the rate of NO inactivation. The present data thus clearly indicate reduced inhibition of NOS, enhanced NO formation, and decreased NO inactivation in low flow regions. It is well known that NO not only plays a decisive role in the control of coronary tone but can also reduce myocardial O 2 consumption. Therefore, a higher NO concentration may even contribute to the lower O 2 consumption and energy turnover of low flow areas. To what extent the increased expression of DDAH1 translates into an enhanced local NO concentration remains to be seen.
Energy metabolism
Low flow areas displayed almost twofold higher levels of glycolytic enzymes (PGK2 and GAPDH), whereas enzymes involved in fatty acid catabolism (HADH and ETF) were downregulated. As a consequence, the importance of glycolysis appears to be greater in low flow areas while conversely in high flow areas fatty acid oxidation may prevail. This apparent shift from ß-oxidation to glycolysis in low flow regions would locally decrease the relative need for O 2 , because the oxidation of glucose requires less O 2 per mole ATP produced (18) . Thus a higher capacity for glycolysis may facilitate the generation of sufficient energy in regions of low O 2 supply. In high flow regions, the enhanced capacity for ß-oxidation is consistent with a higher uptake of fatty acids previously observed (15) and in line with the measured lower absolute lipid content. The greater capacity for fatty acid oxidation in high flow areas will enhance energy supply in areas of elevated energy turnover. In addition, the increased expression of myoglobin might improve O 2 diffusion in regions of high blood flow and energy demand because myoglobin is not only an O 2 storage but also has recently been shown to facilitate O 2 diffusion in the heart (33). However, the lower level of PGK2 and GAPDH in high flow areas is somewhat unexpected, because previous studies demonstrated an enhanced uptake and phosphorylation of deoxyglucose in these areas (14) and reported also an enhanced activity of hexokinase in pooled high flow samples (1) . Because local energy turnover in high flow areas exceeds that of low flow areas at least threefold (17) , not only fatty acid oxidation, but also the amount of glucose oxidized, may be higher than in low flow areas. To elucidate the relative importance of glycolysis and fatty acid oxidation in low and high flow regions, tracer studies of substrate utilization are required. The recent observation in the failing dog heart that decreased levels of NO formation result in a preference for glycolysis (34) adds a further facet to this question.
Structure
Whereas myofibrillar proteins, such as MLC1, MLC2, and tropomyosin, display identical expression in low-and high-flow regions, desmin showed higher expression in high flow areas. On 2D gels of cardiac proteins, desmin appears as a constellation of three adjacent spots with almost identical molecular mass (~52 kDa) but slightly different isoelectric points (pH 5.2-5.5). All three desmin spots showed a higher intensity in the high flow area, but only two of them reached the level of significant alterations. Desmin, a muscle-specific intermediate filament surrounding the Z-discs in mature striated muscles and linking adjacent myofibrils (35) , has been suggested to be essential for maintenance of cellular integrity and force transmission between myofibrils (36) . Recent studies also suggest that desmin, linking myofibrils and mitochondria, may influence mitochondrial respiration (37, 38) . It is thus conceivable that an elevated amount of desmin confers mechanical stability to high flow regions and possibly also contributes to the enhanced energy turnover.
The current study identified differences in protein expression in the areas of energy metabolism, NO metabolism, and myocardial structure. It is well conceivable that differences also exist in other proteins. For example, differential expression of proteins related to Ca 2+ -handling, electrical coupling, and the cross-bridge cycle may have been expected. These proteins could contribute to a spatial distribution of energy demand. However, most of these are rather large or membrane-bound and thus only partially accessible to 2D-PAGE. Protein separation by 2D-PAGE is confined to proteins of a molecular mass from ~10 to ~150 kDa and an isoelectric point ranging from pH 3.0 to 10.0. Lipophilic proteins are underrepresented and proteins, which are present in less than about 10,000 copies per cell, are usually below the level of detection when using silver stain.
Temporal stability of myocardial perfusion
The differences in the proteome pattern observed reflect a long-lasting difference in energy turnover, as indicated by the temporal stability of local flow. So far, the temporal heterogeneity had only been assessed quantitatively for periods of less than 26 h (for review, see ref 7) . The present study extends this observation period to almost 2 weeks and confirms a lasting and high temporal stability. The true temporal heterogeneity of perfusion calculated in the present study (Table 2) is small compared with the true spatial heterogeneity of flow, and near identical to that determined by King and Bassingthwaighte in conscious baboons that were studied for <26 h (11) . This finding suggests that the temporal heterogeneity does not increase with time. This conclusion is supported further by the following observation of the present study: relating the local flow measured on day 1 (or 3, 5, 7, 9, or 11) to that determined on day 13 resulted in similar correlation coefficients (0.84 (day 1 vs. 13) and 0.81 (day 11 vs. 13), respectively).
In consequence, low flow areas remain low flow regions for long periods of time, and high flow regions stay high flow regions. The decisive factor governing local flow is not known presently (39) . It is plausible, however, that the local flow is driven by the local energy demand and local mechanical strain. This theory is supported by the fact that reducing local flow by 50% resulted in similar elevations of lactate and adenosine in low and high flow regions (18) and suggests a comparable coupling of local flow and metabolism in both flow domains.
Functional implications
This study is the first to characterize the molecular basis associated with the spatial heterogeneity of myocardial perfusion and metabolism. Our findings strongly indicate major differences in NO formation and substrate utilization between areas characterized by a persistent low/high local flow and energy turnover. In fact, they unravel a possible homeostatic mechanism by which areas of low local flow and thus limited O 2 supply are protected. In these areas, the local concentration of NO can be expected to be elevated due to impaired NO transport and metabolism (decreased myoglobin) and increased NO formation (increased ADMA dimethylaminohydrolase, less ADMA and thus less NOS inhibition). The elevated NO will result in a greater contribution of NO to the maintenance of vascular tone (31) and an increased O 2 supply. The recent recognition that NO tonically reduces myocardial O 2 consumption and enhances cardiac efficiency (for review [40] ) suggests that a higher NO concentration in low flow areas may even contribute to their lower O 2 consumption. In addition, the higher capacity for glycolysis in low flow areas will reduce the O 2 demand and consumption for a given ATP turnover. These factors together improve the balance between O 2 supply and demand in areas receiving less than 50% of the mean myocardial perfusion, thereby preventing local hypoxia or ischemia. This also might explain the low adenosine and lactate concentrations measured in low flow regions (1, 18) .
The high temporal stability of the local perfusion pattern suggests that external factors possibly related to myocardial fiber architecture and local strain predominantly govern the local energy demand. We would like to suggest that it is the local energy demand, which is the primary force driving local energy turnover and myocardial blood flow, whereas gene and protein expression is modulated by the local needs. Coefficients of variation of local myocardial blood flow. CV obs represents the observed variation of the microsphere measurement at a single point in time ( 46 Sc or yellow-green microsphere application). CV meth represents the overall methodological error as assessed by simultaneous application of two fluorescent microspheres. Taking the complete data set of consecutive microsphere measurements in individual samples into account, CV temp , an index of true temporal heterogeneity was calculated. On the basis of CV obs , CV meth , and CV temp , CV spatial as an index of the true spatial flow heterogeneity was determined. Samples were extracted, and proteins were separated by 2D-PAGE and silver-stained. Most spots show no apparent difference in spot volume (i.e., spot intensity times area). One specific spot (273) is clearly more pronounced in the low flow sample. This spot turned out to be dimethylarginine dimethylaminohydrolase (see Table 1 , Fig. 3 ). Table 1 . Out of an average of 380 protein spots, only 12 spots differed significantly by stringent statistical criteria (n = 30 samples each out of 6 hearts, minimum requirement ∆ 30%.). For details see Materials and Methods. * P < 0.05, ** P < 0.01, *** P < 0.001. (each n = 30 samples) and (B) on the mRNA level (each n = 3 hearts), as well as (C), the concentration of its substrate ADMA (asymmetric dimethylarginine) (each n = 5 -6 hearts) and (D), the mRNA expression of eNOS (endothelial NO synthase) (each n = 3 hearts) in low and high flow samples. * P < 0.05, ** P < 0.01, *** P < 0.001 LF vs. HF. 
